highly significantp < 0.001
In women, we found a highly significant difference in hyperthyroidism prevalence: 11.89% in the HTLV-1 group and 1.85% in the control group ( p < 0.001).
In women, we found a highly significant difference in hyperthyroidism prevalence: 11.89% in the HTLV-1 group and 1.85% in the control group ( p < 0.001).
A positive trend was observed in patients with anti-HTLV-1 antibodies, but no significant difference was observed.